ATR (ataxia telangiectasia-mutated and Rad3-related) protein kinase and ATRIP (ATR-interacting protein) form a complex and play a critical role in response to replication stress and DNA damage. Here, we determined the cryo-electron microscopy (EM) structure of the human ATR-ATRIP complex at 4.7 Å resolution and built an atomic model of the C-terminal catalytic core of ATR (residues 1 521-2 644) at 3.9 Å resolution. The complex adopts a hollow "heart" shape, consisting of two ATR monomers in distinct conformations. The EM map for ATRIP reveals 14 HEAT repeats in an extended "S" shape. The conformational flexibility of ATR allows ATRIP to properly lock the N-termini of the two ATR monomers to favor ATR-ATRIP complex formation and functional diversity. The isolated "head-head" and "tail-tail" each adopts a pseudo 2-fold symmetry. The catalytic pockets face outward and substrate access is not restricted by inhibitory elements. Our studies provide a structural basis for understanding the assembly of the ATR-ATRIP complex and a framework for characterizing ATR-mediated DNA repair pathways.
Introduction
ATM (ataxia telangiectasia-mutated) and ATR (ATMand Rad3-related) are two master regulators of the DNA damage response [1] , which coordinates a number of important cellular processes and is essential for the maintenance of genome integrity and stability in living organisms. ATM and ATR belong to the family of phosphoinositide-3-kinase-related kinases (PIKKs) and share high sequence homology and functional similarity. ATM primarily responds to DNA double-strand breaks (DSBs), whereas ATR is activated by a broader spectrum of DNA damage, including DSBs, crosslinks, and DNA replication stress [2, 3] . ATR is essential for the survival of replicating human and mouse cells, whereas ATM is not [4, 5] . Although ATR gene mutations have been found in only a few patients with the rare Seckel syndrome, disruption of the ATR pathway leads to genomic instability. Therefore, ATR has been proposed to be a cancer drug target and ATR inhibitors are now in clinical trials [6, 7] .
In human cells, the vast majority of ATR exists in complex with ATRIP (ATR-interacting protein). ATR is primarily recruited to replication protein A (RPA) coated single-stranded DNA (ssDNA) [8, 9] , and is further activated by TopBP1 (Topoisomerase (DNA) II Binding Protein 1) [10] and ETAA1 (Ewing tumor-associated antigen 1) [11, 12] . ATR initiates DNA damage responses by phosphorylating a large number of substrates [13] , among which checkpoint kinase 1 (Chk1) is the best characterized [4, 14] .
The ATR signaling pathway has been extensively studied during the past two decades [2, 3] . However, the three-dimensional structure of ATR remains largely unknown due to technical challenges. The related structural studies include structures of mechanistic target of Rapamycin (mTOR) and mTOR complex 1 (mTORC1) [15] [16] [17] , DNA-dependent protein kinase (DNA-PK) [18] [19] [20] , ATM [21] , Mec1-Ddc2 (ATR-ATRIP from Saccharomyces cerevisiae) at 22.5 Å resolution [22] , and truncated ATRIP orthologues from S. cerevisiae and Myceliophthora thermophile [23, 24] . However, these structures provide limited information for fully understanding the assembly and molecular mechanism of ATR-ATRIP.
In this study, we determined the cryo-electron microscopy (EM) structure of human ATR-ATRIP complex. The structure reveals unexpected features for complex assembly and provides significant implications for understanding the mechanisms of ATR-ATRIP complex.
Results

Structure determination
We purified the human ATR-ATRIP complex to homogeneity (Supplementary information, Figure S1A and S1B). The basal kinase activity of ATR-ATRIP was verified in an in vitro kinase assay using purified Chk1 as substrate (Supplementary information, Figure S1C ). The phosphorylation of S345 of Chk1 by ATR-ATIP was largely enhanced in the presence of purified human TopBP1 and was inhibited by a well-characterized ATR inhibitor, VX-970, indicating that a well-folded ATR-ATRIP complex was purified.
We next determined the cryo-EM structure of ATR-ATRIP complex at 4.7 Å resolution using single-particle analysis (Supplementary information, Figure S2 and Movie S1). The structure of ATR C-terminal portion (residues 1 521-2 644) was determined at 3.9 Å resolution. Most of the residues in the C-terminal portion of ATR could be unambiguously assigned using homology modeling with the crystal structure of mTOR kinase domain as a template [17] . The N-terminal portion (~1 400 residues) of ATR was built as poly-Alanine model (Supplementary information, Figure S3 ). The EM map corresponding to ATRIP reveals 14 continuous HEAT repeats (~700 residues) in a pseudo 2-fold symmetry. The structural model (PDB: 5LOI) [23] of the C-terminal part of Rad26 (ATRIP ortholog from Myceliophthora thermophila) could be symmetrically fitted into the map, suggesting an ATRIP dimer in the complex (Supplementary information, Figure S3E ). However, the EM map is not sufficient to determine whether two ATRIP molecules exist in the complex. Therefore, a single poly-Alanine chain was built and referred to as ATRIP hereafter for simplicity.
Overall structure of ATR-ATRIP complex
Like other PIKK kinases, ATR comprises a large N-terminal α-solenoid (containing an N-terminal and a middle HEAT repeats, designated N-HEAT and M-HEAT, respectively), a FAT (FRAP, ATM, TRRAP) domain, a kinase domain (KD), and a C-terminal short segment referred to as FATC ( Figure 1A and Supplementary information, Figure S4A ). The complex reveals a hollow "heart" shape in the front view with overall dimensions of ~180 × 190 × 90 (Å 3 ) ( Figure 1B Figure 1D ). The two N-HEAT domains form "C"-shaped super-helical α-solenoids, which protrude out of the "heads" from two sides and turn down to the "tails" of the complex. ATRIP adopts an extended "S" shape and bridges the N-terminal super-helical regions of two ATR monomers together. The isolated "head-head" (MC ATR -dimer) and "tail-tail" (N-HEAT and ATRIP) each adopts a pseudo 2-fold symmetry ( Figure 1E ). The catalytic pockets of the kinase domains symmetrically face outward from the dimer interface, presenting two open catalytic cavities for substrate phosphorylation.
The N-terminal part (residues 1-1 636) of each ATR monomer has two continuous HEAT repeat regions, the N-HEAT and the M-HEAT ( Figures 1C and 2A left  panel) . Within the N-HEAT, repeats HEAT-1 to HEAT-16 form a right-handed super-helical (~1 turn) α-solenoid, whereas HEAT-17 to HEAT-26 adopt an extended conformation and make a sharp "V"-shaped turn to join with the MC ATR . HEAT-26, the last HEAT repeat of the N-HEAT, directly binds to the three parallel α-helices (fα12-fα14, f represents FAT) of the FAT domain ( Figure  2B ). The EM map was invisible between N-HEAT and M-HEAT due to intrinsic flexibility of the connecting region (Supplementary information, Figure S3A and S3B). The M-HEAT has 12 α-helices packed together and joins with the FAT and the KD domains ( Figures 1C and 2B) .
The M-HEAT and the FAT domains collectively adopt a "C"-shaped conformation and wrap around the kinase domain for ~2/3 turn to form a compact globular fold (Figure 2A and 2B) . The FAT domain contains two TPR (tetraricopeptide) repeats, TPR-1 and TPR-2, followed by a HEAT repeat domain (fα22-fα29) (Figure 2A bottom right panel). In the N-lobe of the KD, the helix kα1 (k represents kinase domain) binds to and stabilizes a six-stranded anti-parallel β-sheet (kβ1-kβ6) ( Figures  2B and 3A) . The C-lobe of the KD is primarily helical with eleven α-helices (kα2-kα12) packed together. The C-terminal FATC domain is integrated into the C-lobe and its C-terminal coil region fills in the gaps between the catalytic loop and a region corresponding to the mLST8-binding elements (LBE) of mTOR ( Figure 3A) . The N-lobe of ATR kinase domain has a unique insert (residues 2 270-2 290) connecting strands kβ1 and kβ2 ( Figures 2B and 3A) . The insert protrudes out of the KD and packs into a deep groove formed by FAT (fα23-fα27) and N-HEAT (HEAT-25 and HEAT-26). mTOR has no such insert and ATM has a similar sequence with weak homology (Supplementary information, Figure S4A ), suggesting distinct inter-domain interactions.
The kinase domain
The ATR kinase domain adopts an overall fold similar to that of mTOR with a root-mean-squared deviation (RMSD) of 2.14 Å for 285 aligned Cα ( Figure 3A and Supplementary information, Figure S5A -S5C). The arrangement of key catalytic residues is highly conserved in ATR and mTOR, suggesting conserved functions of these residues. Residues K2327 and D2330 of ATR support ATP association, whereas residues N2480 and D2494 stabilize Mg 2+ for catalysis ( Figure 3B ). Residue D2475 plays a key role in activating hydroxyl group of substrate for nucleophilic attack, and residue H2477 is important for electrostatic stabilization of the transition state ( Figure 3B ) [17, 25] . Mutations of these residues largely decreased the kinase activity of ATR in the ATR-ATRIP complex ( Figure 3C ), supporting their important role in catalysis.
Structural model for ATR-ATRIP in complex with VX-970 or Chk1 peptide
It has been proposed that ATR could be a promising target for cancer therapy, and ATR inhibitors are now in early-phase clinical trials [6, 7, 26] . VX-970 is a potent and selective ATP competitive inhibitor of ATR with IC 50 of 19 nM in HT29 cells and sensitizes various types of tumor cell lines and cancer models [6] . Docking VX-970 into the structure of ATR kinase domain shows that VX-970 nicely fits into a deep pocket that is assumed to accommodate ATP for substrate phosphorylation ( Figure  3D ). The VX-970 pyrazin-2-amine group extrudes into a deep pocket of ATR kinase domain, which is otherwise occupied by the adenine (purine base) of ATP. The five-membered ring of isoxazole group is close to the ribose of ATP. Most interestingly, the sulfonyl group of VX-970 occupied the position of the γ-phosphate group of ATP and is likely to prevent the transferability of γ-phosphate from ATP to substrate.
We also modeled a Chk1 peptide (residues 343-352), a well-characterized ATR substrate [4, 14] , into the KD structure ( Figure 3E ). The Chk1 peptide packs against a groove formed by the catalytic loop, activation loop and FATC. The peptide extends out of the catalytic cavity without steric hindrance. Residue S345 Chk1 faces toward the catalytic center, and the hydroxyl group is primed to be phosphorylated. Residue Q346 Chk1 , a consensus residue of ATR substrates [13] , nicely fits into a deep pocket. Agreeing with the fact that the EM data were collected in the absence of ATP/ADP, no density was observed in the active site, indicating a native-form kinase domain in the ATR-ATRIP structure.
Structural comparison of ATR and other PIKK family members
We observed three major distinct structural features between ATR and mTOR ( Figure 3A and Supplementary information, Figures S5A-S5C ). (1) Unlike mTOR, ATR lacks an FKBP12-rapamycin-binding (FRB) domain insert. ( 2) The LBE of ATR is different from that of mTOR ( Figure 3A ) [17] , which is consistent with the fact that ATR does not bind to mLST8. (3) The substrate access of mTORC1 is restricted by helix kα9b of mTOR and "V"-shaped cross-section formed by the FRB and mLST8 (Supplementary information, Figure S5B ) [17] . In contrast, the kα9b equivalent in ATR forms a flexible loop that is away from the potential substrate-binding groove ( Figure 3A ), indicating that the kinase domain of ATR is not restricted by inhibitory elements as in mTORC1.
In the 8.7 Å-resolution cryo-EM structure of Tel1/ ATM from S. pombe, Tel1 forms an inactive dimer through head-to-head contacts [27] . Recently, Williams et al. [21] reported two cryo-EM structures of human ATM dimer: one is in a closed form at 4.7 Å resolution, and the other is in an open form (only one protomer was refined) at 5.7 Å resolution. ATM kinase domain in the closed form adopts inhibitory conformation because helices kα9b to kα9d would inhibit substrate access. The helices α21′ and α22′ from the other ATM are important for ATM dimer formation and support the stable localization of kα9b to kα9d within the catalytic pocket. In contrast, the kinase domain in the open form has less ordered inhibitory elements and is predicated to be in active conformation. ATR kinase domain adopts a fold more similar to ATM kinase domain in the open form than to that in the closed form (Supplementary information, Figure  S5D and S5E), supporting our previous observation that ATR lacks inhibitory elements in the ATR-ATRIP complex ( Figure 3A and 3B) . Intriguingly, ATM undergoes a transition from inactive homodimer to active monomer in response to DSBs [28] . Whether ATR undergoes a similar transition remains further investigation.
Structural insight into ATR activation by TopBP1
Previous studies show that ATR undergoes autophosphorylation on residue T1989 and phosphorylated T1989 recruits TopBP1 for the activation of ATR [29, 30] . In our in vitro kinase assays, phosphorylation mimic mutation T1989D (but not T1989A mutant) of ATR was activated by TopBP1 ( Figure 3C ) and the ATR activation domain (AAD, residues 978-1 192) of TopBP1 is sufficient for activation of ATR ( Figure 4B ). Structural analysis shows that residue T1989 is located on the surface of the FAT domain and is unlikely to gain access to any of the two catalytic pockets within the same ATR-ATRIP complex, suggesting a trans-mode autophosphorylation ( Figures  4A and 2A) . The PIKK Regulatory Domain (PRD, residues 2 483-2 597) of ATR and ATRIP (C-terminal coiledcoil domain) are both important for TopBP1-mediated activation. Mutation K2589E does not impair basal kinase activity of ATR but largely decreases its activation by TopBP1 [31] . Since residues T1989 and K2589 both contribute to TopBP1-mediated activation of ATR, it is tempting to speculate that TopBP1 binds to ATR along with the dimer interface ( Figure 4A lower panel) . PRD is part of the kinase domain. Residue K2589 is located within helix kα10, which stabilizes substrate entry groove of the kinase domain ( Figure 4A ). Helix kα10 is followed by a loop involved in intermolecular contacts and its preceding helix, kα9, is predicted to play a role in the regulation of substrate entry. Taken together, TopBP1 might stimulate ATR-ATRIP kinase activity through facilitating substrate access to the catalytic cavity or inducing conformational changes of the kinase domain to favor the catalytic reaction, or some other mechanisms yet to be discovered.
Distinct conformations of two ATR monomers
In the ATR-ATRIP complex structure, the two ATR monomers adopt distinct overall conformations (designated ATR-A and ATR-B; Figure 5A (Figure 5A left panel) . This is also consistent with the observation that the N-HEAT and MC ATR each adopts a pseudo 2-fold symmetry in the complex structure ( Figure 1E) . Therefore, the MC ATR and the N-HEAT act as rigid modules during the conformational switch between ATR-A and ATR-B. The primary switch point is at the interface between HEAT-24 and HEAT-25 within the N-HEAT. An obvious rotation of ~40° of HEAT-25 can be observed when the N-HEAT domains of ATR-A and ATR-B are superimposed ( Figure 5B and 5C) . If the two ATR monomers were to adopt the same (A or B) conformation, the ATR dimer would preclude the ATRIP to simultaneously binds to the N-termini of the two ATR monomers (Supplementary information, Figure S6A-S6C) . Therefore, the conformational flexibility between the N-HEAT and the MC ATR allows the ATR dimer to adopt a proper conformation for ATR-ATRIP complex assembly. Further investigation may reveal whether this conformational switch and/or complex assembly are regulated, e.g., by proline cis-trans isomerization or post-translational modifications.
ATR dimerization
ATR dimerizes through three symmetrically-arranged intermolecular contacts between the two C ATR core regions with a total buried surface area of ~2 700 Å 2 ( Figure  6A ). (1) Two parallel α-helices (fα7-fα8) of the two FAT domains bind to each other. (2) Helices fα17-fα19 of one ATR monomer interact with helices fα5-fα6 and kα11 of the other ATR monomer. (3) A loop (residues 2 600-2 615) and the following helix kα11 of one ATR monomer pack against the surface formed by helices fα19-fα22 of the other ATR monomer. The regions involved in ATR dimer formation are highly conserved, supporting their significance for ATR function ( Figure 6B ).
Unlike ATR-ATRIP, mTORC1 adopts a hollow "rhomboid" shape with a 2-fold symmetry and mTOR dimerizes through intermolecular contacts between two HEAT repeats, corresponding to the N-HEAT and M-HEAT in ATR (Supplementary information, Figure S5A ). The C-terminal regions (corresponding to C ATR ) of two mTOR monomers have no direct contacts and are located at two apical sites of the "rhomboid"-shaped structure [15, 16] . M-HEAT mTOR is much longer than M-HEAT ATR and is involved in dimer formation of mTORC1. When the C-terminal domains of mTOR and ATR are superimposed, the relative positions between FAT and N-HEAT at the switch point are different, leading to distinct overall conformations for their N-HEAT regions. Notably, the topology of ATR is similar to that of mTOR in the human mTORC1 structure [15, 16] 
and S5C).
ATRIP and complex assembly
Previous studies show that ATRIP forms a dimer through a coiled-coil region (residues 112-225) and deletion/mutation of the coiled-coil region partially impaired ATR-ATRIP complex formation (Supplementary information, Figure S4B ) [5, 32, 33] . We next performed co-immunoprecipitation using full-length ATR and various ATRIP truncations to investigate the interaction between ATR and ATRIP (Supplementary information, Figure S7A) . Compared with full-length ATRIP (ATRIP FL ), ATRIP ∆1-217 and ATRIP ∆112-225 showed slightly decreased binding affinity to ATR. ATRIP ∆1-400 , ATRIP ∆401-791 , and various C-terminal truncations of ATRIP largely impaired ATR-ATRIP formation. These results are consistent with previous studies [5, 33] , and indicate that N-and C-terminal regions of ATRIP are both important for stable complex formation.
The cryo-EM density corresponding to ATRIP indicates 14 continuous HEAT repeats. ATRIP adopts an extended "S" shape with its two termini locking the N-termini of two ATR monomers. ATRIP binds to the two ATR monomers in an almost identical manner, suggesting that ATR forms a symmetric dimer in the complex ( Figure 7B ). Three contacts were observed in each ATR-ATRIP interaction ( Figure 7A ). To test whether ATRIP is essential for ATR dimerization, we performed gel filtration analyses using purified proteins. The results indicate that ATR forms a dimer in the absence of ATRIP (Supplementary information, Figure S7B ), consistent with the observation that ATR dimerizes through extensive head-to-head contacts (Figure 6) . Therefore, ATR-ATRIP complex may provide a framework for recruiting other regulatory proteins. For example, TopBP1 stimulates ATR kinase activity in an ATRIP-dependent manner [10, 31] , and RPA-coated ssD-NA binds to the N-terminus (residues 1-108) of ATRIP and recruits ATR to DNA damage-induced foci [8, 34] .
Discussion
ATR and ATRIP form a stable complex and serve as a key player in controlling DNA repair in response to replication stress and DNA damage. In this study, we purified human ATR-ATRIP complex to homogeneity and determined the cryo-EM structure. The study provides structural basis for understanding complex assembly and ATR-mediated DNA repair pathway.
The ATR-ATRIP complex was purified through affinity purification, cation exchange and gel filtration so that extra ATR or ATRIP molecules should have been separated from the ATR-ATRIP complex. The proper folding of the complex was verified by the in vitro kinase assays. The ATR-ATRIP complex is catalytically active and its kinase activity could be stimulated by TopBP1. Therefore, the ATR-ATRIP complex that we purified is functional in the in vitro system.
Previous studies show that ATRIP forms a dimer through the coiled-coil region (residues 112-225) [5, 33, 35] . We did not observe the coiled-coil region according to the EM map. Moreover, our EM and biochemical analyses were not sufficient to unambiguously determine the stoichiometry of ATR and ATRIP in the ATR-ATRIP complex. Further studies, especially a high-resolution structure of the ATR-ATRIP complex, will provide the underlying mechanism for potential ATRIP dimerization and ATR-ATRIP complex assembly.
ATR dimerizes in a manner distinct from ATM [21] and mTOR in the mTORC1 complex [15, 16] . Two ATR monomers adopt distinct conformations within one ATR-ATRIP complex. The switch point is located in the N-HEAT of ATR. Such conformational flexibility may be correlated with its functional diversity or regulation. Similar conformational flexibility was observed in our recent study of DNA-PK (DNA-dependent protein kinase) holoenzyme. Upon holoenzyme formation, KU70/80 and DNA bind to DNA-PKcs (DNA-PK catalytic subunit) and stimulate the kinase activity through altering the conformation of its N-HEAT domain [18] .
The catalytic pocket of ATR opens outward and is not restricted by inhibitory elements. The kinase activity could be stimulated by TopBP1 [10] and ETAA1 [11, 12] . Our structural and biochemical analyses suggest that TopBP1 may stimulate ATR-ATRIP kinase activity through facilitating substrate association or inducing conformational changes of the kinase domain. Notably, we could only observe strong activation under low salt (~50 mM NaCl) conditions ( Figure 3C and Supplementary information, Figure S1C ). Such observation is consistent with previous studies [10, 31, 36] , suggesting a weak interaction between TopBP1 and ATR-ATRIP. This might explain why we could not obtain a stable complex of ATR-ATRIP-TopBP1 for structural analysis (data not shown). During revision of this manuscript, Wang et al. [37] reported 3.9 Å structure of the Mec1-Ddc2 complex, the yeast homolog of ATR-ATRIP. The structure shows a dimer of heterodimer and the coiled-coil domain of Ddc2 (ATRIP) could be traced. Intriguingly, the authors found that the activation loop of Mec1 is inhibited by the PRD. However, we did not observe such inhibition in the human ATR-ATRIP structure ( Figure 3A ). It remains unknown what leads to such a distinct feature.
Materials and Methods
Reagents
Antibodies against phospho-Ser345 Chk1 (Cat# 2348) was from Cell Signaling Technology; horseradish peroxidase-labeled anti-rabbit secondary antibody was from AbMart; anti-Flag M2 affinity agarose gel was from Sigma; Mono S and Superose 6 (5/150 GL) were from GE Healthcare; polyethylenimine (PEI) was from Polysciences (23966); ATR inhibitor, VX-970, was from Selleck.
Protein expression and purification
The ORFs of human ATR and ATRIP were individually subcloned into a modified pCAG vector, which contains N-terminal FLAG tag, protein A tag, and 3C protease cutting site followed by MCS (multiple cloning sites). The two plasmids were co-transfected into 293F cells using PEI. After cultured at 37 °C for 3 days, cells were harvested and lysed in buffer containing 50 mM HEPES (pH 7.4), 150 mM NaCl, 10% glycerol, 0.25% Tween-20, and 3 mM DTT, 2 mM MgCl 2 , 1 mM PMSF, 1 µg/ml pepstatin, 1 µg/ml leupeptin, 1 µg/ml aprotinin at 4 °C for 1 h. Supernatants were incubated with anti-Flag M2 affinity agarose gel for 2 h, and unbound proteins were extensively washed away with a buffer containing 50 mM HEPES (pH 7.4), 150 mM NaCl, 5 mM ATP, 10 mM MgCl 2 and 3 mM DTT. The fusion proteins were digested using 3C protease overnight and eluted with a buffer containing 20 mM HEPES (pH 7.4), 150 mM NaCl and 3 mM DTT. The eluted proteins were further purified using a cation exchange column (Mono S) under Bis-Tris (pH 6.0) buffer with increasing concentration of NaCl from 0 to 1 000 mM. ATRIP in excess was eluted out when NaCl concentration reached to 150-250 mM, whereas ATR-ATRIP complex was out in 300-500 mM NaCl. Gel filtration chromatography (Superose 6) was performed in a buffer containing 20 mM HEPES (pH 7.4), 200 mM NaCl and 5 mM TCEP. The peak fractions were pooled for biochemical and structural analyses (Supplementary information, Figure S1B ). ATR or ATRIP plasmid was transfected to 293F cells individually. The proteins were overexpressed and purified using similar procedures under similar conditions.
In vitro kinase assays
The in vitro kinase assays were performed in a buffer containing 20 mM HEPES (pH 7.4), 50 mM NaCl, 5 mM MgCl 2 , 1 mM DTT and 1 mM ATP for 30 min at 30 °C. For ATR activation or inhibition assay, ATR-ATRIP and TopBP1 were preincubated with TopBP1 or VX-970 for 10 min at 30 °C before adding Chk1. Reactions were terminated by addition of SDS sample loading buffer and boiling for 5 min. Samples were subjected to SDS-PAGE and immunoblotting. The kinase-dead Chk1 (D130A) was used to avoid Chk1 autophosphorylation.
Co-immunoprecipitation
Full-length ATR plasmid (FLAG-tagged but does not contain protein A tag) and various truncations of ATRIP plasmid (with N-terminal FLAG tag and protein A tag) were co-transfected into 293F cells and cultured for 2 days. The cells (40 ml for each immunoprecipitation) were harvested and lysed with buffer containing 50 mM HEPES (pH 7.4), 150 mM NaCl, 10% glycerol, 0.25% Tween-20, 2 mM MgCl 2 , and 3 mM DTT, 1 mM PMSF, 1 µg/ml pepstatin, 1 µg/ml leupeptin, 1 µg/ml aprotinin. Supernatants was incubated with 15 µl IgG resins for 2 h, and resins were extensively washed three times with buffer containing 50 mM HEPES (pH 7.4), 500 mM NaCl, 10 mM MgCl 2 , 5 mM ATP and 3 mM DTT. The bound proteins were subjected to SDS-PAGE and stained by Coomassie blue.
EM data acquisition
For cryo-EM grid preparation, aliquots of 4 µl of freshly purified ATR-ATRIP complex (~0.35 mg/ml) were applied to glow-discharged holey carbon grids (Quantifoil Cu, R1.2/1.3, 400 mesh). The grids were then blotted for 3 s and flash-plunged into liquid ethane pre-cooled by liquid nitrogen using an FEI Vitrobot mark IV operated at 10 °C and 100% humidity. Good cryo-EM grids were loaded onto an FEI Titan Krios microscope equipped with a Cs corrector and K2 Summit camera for data collection at National Center for Protein Science Shanghai (NCPSS). All the cryo-EM images were manually recorded at a super-resolution mode, using a nominal magnification of 18 000, corresponding to a final pixel size of 1.3 Å after decimating the original micrographs twice. For each image stack, a total dose of about 50 electrons were equally fractioned into 32 frames with a total exposure time of 8 s. Defocus values used to collect the dataset ranged from -1.8 to -4.5 μm.
Image processing
For cryo-EM data, beam-induced motion correction was performed using the MotionCor2 to generate average micrographs and dose-weighting micrographs from all frames [38] . The contrast transfer function parameters were estimated by CTFFIND3 [39] from average micrographs and other procedures of cryo-EM data processing were performed within RELION 1.4 using the dose-weighted micrographs [40] . About 3 000 manually picked particles were used to generate the templates for particle auto-picking and about 1 200 000 particles were auto-picked from 3 031 micrographs for further processing. After one round of reference-free 2D classification, 610 135 particles were then subjected to 3D classification with the EM map reconstructed from the negatively stained specimen (data not shown) as the initial model with a lowpass filtered to 60 Å. Next, 266 218 particles within the best classes were grouped and used for refinement to converge into a map with a reported resolution of 6.12 Å (gold-standard FSC 0.143 criteria) [41] . A reported 4.72 Å resolution (corrected gold-standard FSC 0.143 criteria) map was generated after B-factor sharpening with a B-factor of -267 Å 2 (post-processing in RELION) (Supplementary information, Figure S2 ). Further refinements with local masks [42] were performed subsequently, leading to improved local maps. To improve the resolution of the core region, we subtracted the rest parts from the raw particles to generate a dataset only containing the core region [43] . A final refinement of the core region was performed with the imposition of a C2 symmetry. A reported 3.94 Å (Supplementary information, Figure S2 ) map was generated after B-factor sharpening with a B-factor of -180 Å 2 . All the visualization and evaluation of the map was performed within Chimera [44] , and the local resolution map was calculated using ResMap [45] . The procedures for data collection are summarized in Supplementary information, Figure S2 .
Model building into the cryo-EM map
The crystal structure of mTOR (1 385-2 549 aa) (PDB ID: 4JSN) [17] was sculpted using phaser.sculptor [46] according to the sequence alignment between mTOR and ATR, and then docked into the ATR-ATRIP cryo-EM map using UCSF Chimera [44] . The rest parts of ATR including N-HEAT and M-HEAT domains and ATRIP were built by placing the ideal α-helices into the map using COOT [47] . Although the resolution of the core domain (FAT, KD and FATC) is only 3.94 Å, the high sequence identity in this region between mTOR and ATR and the clarity of the bulk-residue cryo-EM map provide the correct sequence register for the core domain, especially the kinase domain (Supplementary information, Figure  S3 ). In the ATR-ATRIP model, the C-terminal part (residues 1 521-2 644) of ATR was built according to the high quality cryo-EM map at 3.94 Å resolution, whereas the N-terminal part of ATR (~1 400 residues) and the majority of ATRIP (698 out of 791 residues) were built using poly-Ala based on the well-defined secondary structure from the EM map at 4.72 Å resolution (Supplementary information, Figure S3 ). The topology of the whole structure was refined with MDFF [48] against the 4.72 Å map and the atomic model of ATR C-terminal part was partially refined with phenix.real_space_refine [49] against the 3.94 Å locally refined map. The final statistics are listed in Supplementary information, Table S1 .
The intrinsic flexibility of the N-terminal HEAT repeats of ATR and ATRIP may lead to the difficulty in improving the resolution of complex reconstruction. Similar conformational flexibility of HEAT repeats has been observed in other proteins such as PP2A and mTORC1 complexes [15, 16, 50] . The cryo-EM map showed well-defined secondary structural elements at the N-terminal part of ATR and ATRIP and clear side-chain features at the C-terminal part of ATR, which allows us at least to build the atomic model of the C-terminal part of ATR, especially the catalytic core region (Supplementary information, Figure S3 ).
VX-970 docking and Chk1 peptide modeling
VX-970 was docked into the kinase domain of ATR using AutoDock Vina [51] , and the top ranked result gives the most reasonable conformation as described in the text. To identify the possible peptide and ATP position, the crystal structure of pCDK2 bound with peptide (PDB ID: 3QHW) [52] was superposed onto the KD domain of ATR, and then the peptide sequence was mutated according to the Chk1 sequence.
Accession codes
The electron density map and corresponding atomic coordinates have been deposited in the Protein Data Bank (http://www. rcsb.org/pdb) with code: 5YZ0 and EMDB (http://www.ebi.ac.uk/ pdbe/emdb/) with codes: EMD-6862 for the ATR-ATRIP complex at 4.7 Å resolution and EMD-6863 for the C-terminal catalytic core (residues 1 521-2 644) of the ATR dimer at 3.9 Å resolution.
